The correlation between the proportion of patients with pancreatic ductal adenocarcinoma who received neoadjuvant therapy and overall survival between 2004 and 2015.

被引:1
|
作者
Molina, George [1 ]
Chawla, Akhil [1 ]
Clancy, Thomas E. [1 ]
Wang, Jiping [1 ]
机构
[1] Brigham & Womens Hosp, Dana Farber Canc Inst, 75 Francis St, Boston, MA 02115 USA
关键词
D O I
10.1200/JCO.2019.37.4_suppl.395
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
395
引用
收藏
页数:1
相关论文
共 50 条
  • [1] The Association between Sampling and Survival in Patients with Pancreatic Ductal Adenocarcinoma Who Received Neoadjuvant Therapy and Pancreaticoduodenectomy
    Taherian, Mehran
    Katz, Matthew H. G.
    Prakash, Laura R.
    Wei, Dongguang
    Tong, Yi Tat
    Lai, Zongshan
    Chatterjee, Deyali
    Wang, Hua
    Kim, Michael
    Tzeng, Ching-Wei D.
    Ikoma, Naruhiko
    Wolff, Robert A.
    Zhao, Dan
    Koay, Eugene J.
    Maitra, Anirban
    Wang, Huamin
    CANCERS, 2024, 16 (19)
  • [2] The Impact of Sampling on Survival in Patients with Pancreatic Ductal Adenocarcinoma Who Received Neoadjuvant Therapy and Pancreaticoduodenectomy
    Taherian, Mehran
    Katz, Matthew
    Prakash, Laura
    Tong, Yi Tat
    Lai, Zongshan
    Chatterjee, Deyali
    Wang, Hua
    Kim, Michael
    Tzeng, Ching-Wei
    Ikoma, Naruhiko
    Wolff, Robert A.
    Zhao, Dan
    Koay, Eugene
    Maitra, Anirban
    Wang, Huamin
    LABORATORY INVESTIGATION, 2023, 103 (03) : S1529 - S1530
  • [3] Integrated Pathologic Score Effectively Stratifies Patients With Pancreatic Ductal Adenocarcinoma Who Received Neoadjuvant Therapy and Pancreaticoduodenectomy
    Sohn, Aaron J.
    Taherian, Mehran
    Katz, Matthew H. G.
    Prakash, Laura R.
    Chatterjee, Deyali
    Wang, Hua
    Kim, Michael
    Tzeng, Ching-Wei D.
    Lee, Jeffrey E.
    Ikoma, Naruhiko
    Rashid, Asif
    Wolff, Robert A.
    Zhao, Dan
    Koay, Eugene J.
    Sun, Ryan
    Maitra, Anirban
    Wang, Huamin
    AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2023, 47 (04) : 421 - 430
  • [4] Integrated Pathologic Score Effectively Stratifies Patients with Pancreatic Ductal Adenocarcinoma Who Received Neoadjuvant therapy and Pancreaticoduodenectomy
    Sohn, Aaron
    Katz, Matthew
    Prakash, Laura
    Chatterjee, Deyali
    Wang, Hua
    Kim, Michael
    Tzeng, Ching-Wei
    Lee, Jeffrey
    Ikoma, Naruhiko
    Rashid, Asif
    Wolff, Robert A.
    Zhao, Dan
    Koay, Eugene
    Maitra, Anirban
    Wang, Huamin
    MODERN PATHOLOGY, 2022, 35 (SUPPL 2) : 1233 - 1233
  • [5] Integrated Pathologic Score Effectively Stratifies Patients with Pancreatic Ductal Adenocarcinoma Who Received Neoadjuvant therapy and Pancreaticoduodenectomy
    Sohn, Aaron
    Katz, Matthew
    Prakash, Laura
    Chatterjee, Deyali
    Wang, Hua
    Kim, Michael
    Tzeng, Ching-Wei
    Lee, Jeffrey
    Ikoma, Naruhiko
    Rashid, Asif
    Wolff, Robert A.
    Zhao, Dan
    Koay, Eugene
    Maitra, Anirban
    Wang, Huamin
    LABORATORY INVESTIGATION, 2022, 102 (SUPPL 1) : 1233 - 1233
  • [6] Evaluation of Pathologic Response on Overall Survival After Neoadjuvant Therapy in Pancreatic Ductal Adenocarcinoma
    Sell, Naomi M.
    Lee, Grace C.
    Fernandez-Del Castillo, Carlos
    Ferrone, Cristina R.
    Warshaw, Andrew L.
    Hong, Theodore S.
    Blaszkowsky, Lawrence S.
    Lillemoe, Keith D.
    Qadan, Motaz
    PANCREAS, 2020, 49 (07) : 897 - 903
  • [7] Correlation Between Antihypertensive Drugs and Survival Among Patients with Pancreatic Ductal Adenocarcinoma
    Kluz, Natalia
    Kraj, Leszek
    Chmiel, Paulina
    Przybylkowski, Adam M.
    Wyrwicz, Lucjan
    Stec, Rafal
    Szymanski, Lukasz
    CANCERS, 2024, 16 (23)
  • [8] Survival of patients with resectable pancreatic cancer who received neoadjuvant therapy
    Christians, Kathleen K.
    Heimler, Jonathan W.
    George, Ben
    Ritch, Paul S.
    Erickson, Beth A.
    Johnston, Fabian
    Tolat, Parag P.
    Foley, William D.
    Evans, Douglas B.
    Tsai, Susan
    SURGERY, 2016, 159 (03) : 893 - 900
  • [9] Prognosticators for Patients with Pancreatic Ductal Adenocarcinoma Who Received Neoadjuvant FOLFIRINOX or Gemcitabine/Nab-Paclitaxel Therapy and Pancreatectomy
    Tong, Yi Tat
    Lai, Zongshan
    Katz, Matthew H. G.
    Prakash, Laura R.
    Wang, Hua
    Chatterjee, Deyali
    Kim, Michael
    Tzeng, Ching-Wei D.
    Lee, Jeffrey E. E.
    Ikoma, Naruhiko
    Rashid, Asif
    Wolff, Robert A.
    Zhao, Dan
    Koay, Eugene J.
    Maitra, Anirban
    Wang, Huamin
    CANCERS, 2023, 15 (09)
  • [10] Pathologic Prognosticators for Patients with Pancreatic Ductal Adenocarcinoma Who Received Neoadjuvant FOLFIRINOX or Gemcitabine/Nab-Paclitaxel Therapy
    Tong, Yi Tat
    Lai, Zongshan
    Katz, Matthew
    Prakash, Laura
    Wang, Hua
    Chatterjee, Deyali
    Kim, Michael
    Tzeng, Ching-Wei
    Lee, Jeffrey
    Ikoma, Naruhiko
    Rashid, Asif
    Wolff, Robert A.
    Zhao, Dan
    Koay, Eugene
    Maitra, Anirban
    Wang, Huamin
    MODERN PATHOLOGY, 2022, 35 (SUPPL 2) : 1236 - 1236